aluates Reports

$ 0.0

Automative

Global NAD+ Enhancer Market Research Report 2026

Published Date: 2026-02-06

Report Code: QYRE-Auto-0M16591

Global NAD Enhancer Market Research Report 2023

BUY CHAPTERS

Global NAD+ Enhancer Market Research Report 2026

Code: QYRE-Auto-0M16591

Report

2026-02-06

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Genex Formulas

Elysium Health

GeneHarbor

Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

Herbalmax

EffePharm

Kingdomway

NOMON Co., Ltd. (Teijin)

CELFULL

Bontac

EZZ

Maac10 Formulas

Niagen Bioscience

NAD+ Enhancer Market Size

The global NAD+ Enhancer market was valued at US$ 577 million in 2025 and is anticipated to reach US$ 1528 million by 2032, at a CAGR of 15.2% from 2026 to 2032.

NAD+ Enhancer Market

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells. It plays a crucial role in various biological processes, including energy metabolism, DNA repair, and gene expression. Some people are interested in NAD+ enhancers, which are substances or compounds that may support or increase the levels of NAD+ in the body.

Strong Market Growth Driven by Aging Population and Longevity Demand

The NAD+ booster capsule market is expected to maintain strong growth as global populations age and consumer awareness of longevity, cellular health, and metabolic wellness increases. Capsules remain the most commercially scalable and accessible format, making them the preferred product type for retail brands. Demand is expanding rapidly in North America, Europe, Japan, and China, driven by rising interest in anti-aging science and the shift toward preventive healthcare.

Scientific Validation and Ingredient Innovation Accelerate Adoption

Future development will be shaped by increasing clinical research on NMN, NR, and other NAD+ precursors, which is improving consumer trust and regulatory acceptance. Innovation in stabilization technology, sustained-release capsules, and enhanced-bioavailability formulations (such as liposomal or microencapsulated NAD+ boosters) is expected to differentiate brands and raise product efficacy. Companies are also developing novel precursor combinations to expand the biological pathways for NAD+ synthesis.

Regulatory Standardization and Quality Compliance Will Become Critical

As NAD+ boosters gain popularity, more stringent global regulations are emerging to ensure safety, purity, and label accuracy—especially in the U.S., EU, and China. The industry is shifting toward pharmaceutical-grade manufacturing, third-party testing, and validated human trials. Brands able to meet future compliance standards and provide transparent clinical data will dominate premium segments, while lower-quality manufacturers may be pressured out of the market.

Expansion into Personalized Nutrition and Integrated Health Ecosystems

Future growth will increasingly come from personalized supplementation, digital health integration, and subscription-based models. NAD+ booster capsules will be combined with biomarker testing, mitochondrial support formulas, gut-health products, and AI-driven health monitoring platforms. Partnerships with longevity clinics, anti-aging centers, and wellness programs will help capsules evolve from stand-alone supplements into components of broader metabolic and cellular-health ecosystems.

This report delivers a comprehensive overview of the global NAD+ Enhancer market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding NAD+ Enhancer. The NAD+ Enhancer market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global NAD+ Enhancer market comprehensively. Regional market sizes by Type, by Application, by Form, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist NAD+ Enhancer manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of NAD+ Enhancer Market Report

Report Metric	Details
Report Name	NAD+ Enhancer Market
Accounted market size in 2025	US$ 577 million
Forecasted market size in 2032	US$ 1528 million
CAGR	15.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Content ＜98% Content ≥98%
Segment by Form	Powder Liquid Others
Segment by Ingestion Method	Dietary Supplements Pharmaceutical Drugs Functional Foods & Beverages IV Infusion Products Others
Segment by Application	Health Care Products ClinicsBeauty Products Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GeneHarbor, Niagen Bioscience, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Herbalmax, EffePharm, Kingdomway, NOMON Co., Ltd. (Teijin), CELFULL, Bontac, Genex Formulas, EZZ, Maac10 Formulas, Elysium Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for NAD+ Enhancer companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is NAD+ Enhancer Market growing?

Ans: The NAD+ Enhancer Market witnessing a CAGR of 15.2% during the forecast period 2026-2032.

What is the NAD+ Enhancer Market size in 2032?

Ans: The NAD+ Enhancer Market size in 2032 will be US$ 1528 million.

Who are the main players in the NAD+ Enhancer Market report?

Ans: The main players in the NAD+ Enhancer Market are GeneHarbor, Niagen Bioscience, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Herbalmax, EffePharm, Kingdomway, NOMON Co., Ltd. (Teijin), CELFULL, Bontac, Genex Formulas, EZZ, Maac10 Formulas, Elysium Health

What are the Application segmentation covered in the NAD+ Enhancer Market report?

Ans: The Applications covered in the NAD+ Enhancer Market report are Health Care Products, ClinicsBeauty Products, Others

What are the Type segmentation covered in the NAD+ Enhancer Market report?

Ans: The Types covered in the NAD+ Enhancer Market report are Content ＜98%, Content ≥98%

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NAD+ Enhancer Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Content ＜98%

1.2.3 Content ≥98%

1.3 Market by Form

1.3.1 Global NAD+ Enhancer Market Size Growth Rate by Form: 2021 vs 2025 vs 2032

1.3.2 Powder

1.3.3 Liquid

1.3.4 Others

1.4 Market by Ingestion Method

1.4.1 Global NAD+ Enhancer Market Size Growth Rate by Ingestion Method: 2021 vs 2025 vs 2032

1.4.2 Dietary Supplements

1.4.3 Pharmaceutical Drugs

1.4.4 Functional Foods & Beverages

1.4.5 IV Infusion Products

1.4.6 Others

1.5 Market by Application

1.5.1 Global NAD+ Enhancer Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Health Care Products

1.5.3 ClinicsBeauty Products

1.5.4 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global NAD+ Enhancer Market Perspective (2021–2032)

2.2 Global NAD+ Enhancer Growth Trends by Region

2.2.1 Global NAD+ Enhancer Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 NAD+ Enhancer Historic Market Size by Region (2021–2026)

2.2.3 NAD+ Enhancer Forecasted Market Size by Region (2027–2032)

2.3 NAD+ Enhancer Market Dynamics

2.3.1 NAD+ Enhancer Industry Trends

2.3.2 NAD+ Enhancer Market Drivers

2.3.3 NAD+ Enhancer Market Challenges

2.3.4 NAD+ Enhancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NAD+ Enhancer Players by Revenue

3.1.1 Global Top NAD+ Enhancer Players by Revenue (2021–2026)

3.1.2 Global NAD+ Enhancer Revenue Market Share by Players (2021–2026)

3.2 Global Top NAD+ Enhancer Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by NAD+ Enhancer Revenue

3.4 Global NAD+ Enhancer Market Concentration Ratio

3.4.1 Global NAD+ Enhancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NAD+ Enhancer Revenue in 2025

3.5 Global Key Players of NAD+ Enhancer Head Offices and Areas Served

3.6 Global Key Players of NAD+ Enhancer, Products and Applications

3.7 Global Key Players of NAD+ Enhancer, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 NAD+ Enhancer Breakdown Data by Type

4.1 Global NAD+ Enhancer Historic Market Size by Type (2021–2026)

4.2 Global NAD+ Enhancer Forecasted Market Size by Type (2027–2032)

5 NAD+ Enhancer Breakdown Data by Application

5.1 Global NAD+ Enhancer Historic Market Size by Application (2021–2026)

5.2 Global NAD+ Enhancer Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America NAD+ Enhancer Market Size (2021–2032)

6.2 North America NAD+ Enhancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America NAD+ Enhancer Market Size by Country (2021–2026)

6.4 North America NAD+ Enhancer Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NAD+ Enhancer Market Size (2021–2032)

7.2 Europe NAD+ Enhancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe NAD+ Enhancer Market Size by Country (2021–2026)

7.4 Europe NAD+ Enhancer Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific NAD+ Enhancer Market Size (2021–2032)

8.2 Asia-Pacific NAD+ Enhancer Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific NAD+ Enhancer Market Size by Region (2021–2026)

8.4 Asia-Pacific NAD+ Enhancer Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America NAD+ Enhancer Market Size (2021–2032)

9.2 Latin America NAD+ Enhancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America NAD+ Enhancer Market Size by Country (2021–2026)

9.4 Latin America NAD+ Enhancer Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NAD+ Enhancer Market Size (2021–2032)

10.2 Middle East & Africa NAD+ Enhancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa NAD+ Enhancer Market Size by Country (2021–2026)

10.4 Middle East & Africa NAD+ Enhancer Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GeneHarbor

11.1.1 GeneHarbor Company Details

11.1.2 GeneHarbor Business Overview

11.1.3 GeneHarbor NAD+ Enhancer Introduction

11.1.4 GeneHarbor Revenue in NAD+ Enhancer Business (2021–2026)

11.1.5 GeneHarbor Recent Development

11.2 Niagen Bioscience

11.2.1 Niagen Bioscience Company Details

11.2.2 Niagen Bioscience Business Overview

11.2.3 Niagen Bioscience NAD+ Enhancer Introduction

11.2.4 Niagen Bioscience Revenue in NAD+ Enhancer Business (2021–2026)

11.2.5 Niagen Bioscience Recent Development

11.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

11.3.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Details

11.3.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview

11.3.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Introduction

11.3.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Revenue in NAD+ Enhancer Business (2021–2026)

11.3.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Development

11.4 Herbalmax

11.4.1 Herbalmax Company Details

11.4.2 Herbalmax Business Overview

11.4.3 Herbalmax NAD+ Enhancer Introduction

11.4.4 Herbalmax Revenue in NAD+ Enhancer Business (2021–2026)

11.4.5 Herbalmax Recent Development

11.5 EffePharm

11.5.1 EffePharm Company Details

11.5.2 EffePharm Business Overview

11.5.3 EffePharm NAD+ Enhancer Introduction

11.5.4 EffePharm Revenue in NAD+ Enhancer Business (2021–2026)

11.5.5 EffePharm Recent Development

11.6 Kingdomway

11.6.1 Kingdomway Company Details

11.6.2 Kingdomway Business Overview

11.6.3 Kingdomway NAD+ Enhancer Introduction

11.6.4 Kingdomway Revenue in NAD+ Enhancer Business (2021–2026)

11.6.5 Kingdomway Recent Development

11.7 NOMON Co., Ltd. (Teijin)

11.7.1 NOMON Co., Ltd. (Teijin) Company Details

11.7.2 NOMON Co., Ltd. (Teijin) Business Overview

11.7.3 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Introduction

11.7.4 NOMON Co., Ltd. (Teijin) Revenue in NAD+ Enhancer Business (2021–2026)

11.7.5 NOMON Co., Ltd. (Teijin) Recent Development

11.8 CELFULL

11.8.1 CELFULL Company Details

11.8.2 CELFULL Business Overview

11.8.3 CELFULL NAD+ Enhancer Introduction

11.8.4 CELFULL Revenue in NAD+ Enhancer Business (2021–2026)

11.8.5 CELFULL Recent Development

11.9 Bontac

11.9.1 Bontac Company Details

11.9.2 Bontac Business Overview

11.9.3 Bontac NAD+ Enhancer Introduction

11.9.4 Bontac Revenue in NAD+ Enhancer Business (2021–2026)

11.9.5 Bontac Recent Development

11.10 Genex Formulas

11.10.1 Genex Formulas Company Details

11.10.2 Genex Formulas Business Overview

11.10.3 Genex Formulas NAD+ Enhancer Introduction

11.10.4 Genex Formulas Revenue in NAD+ Enhancer Business (2021–2026)

11.10.5 Genex Formulas Recent Development

11.11 EZZ

11.11.1 EZZ Company Details

11.11.2 EZZ Business Overview

11.11.3 EZZ NAD+ Enhancer Introduction

11.11.4 EZZ Revenue in NAD+ Enhancer Business (2021–2026)

11.11.5 EZZ Recent Development

11.12 Maac10 Formulas

11.12.1 Maac10 Formulas Company Details

11.12.2 Maac10 Formulas Business Overview

11.12.3 Maac10 Formulas NAD+ Enhancer Introduction

11.12.4 Maac10 Formulas Revenue in NAD+ Enhancer Business (2021–2026)

11.12.5 Maac10 Formulas Recent Development

11.13 Elysium Health

11.13.1 Elysium Health Company Details

11.13.2 Elysium Health Business Overview

11.13.3 Elysium Health NAD+ Enhancer Introduction

11.13.4 Elysium Health Revenue in NAD+ Enhancer Business (2021–2026)

11.13.5 Elysium Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Genex Formulas

Elysium Health

GeneHarbor

Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

Herbalmax

EffePharm

Kingdomway

NOMON Co., Ltd. (Teijin)

CELFULL

Bontac

EZZ

Maac10 Formulas

Niagen Bioscience

List of Tables

Table 1. Global NAD+ Enhancer Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Content ＜98%

Table 3. Key Players of Content ≥98%

Table 4. Global NAD+ Enhancer Market Size Growth Rate by Form (US$ Million): 2021 vs 2025 vs 2032

Table 5. Key Players of Powder

Table 6. Key Players of Liquid

Table 7. Key Players of Others

Table 8. Global NAD+ Enhancer Market Size Growth Rate by Ingestion Method (US$ Million): 2021 vs 2025 vs 2032

Table 9. Key Players of Dietary Supplements

Table 10. Key Players of Pharmaceutical Drugs

Table 11. Key Players of Functional Foods & Beverages

Table 12. Key Players of IV Infusion Products

Table 13. Key Players of Others

Table 14. Global NAD+ Enhancer Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 15. Global NAD+ Enhancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 16. Global NAD+ Enhancer Market Size by Region (US$ Million), 2021–2026

Table 17. Global NAD+ Enhancer Market Share by Region (2021–2026)

Table 18. Global NAD+ Enhancer Forecasted Market Size by Region (US$ Million), 2027–2032

Table 19. Global NAD+ Enhancer Market Share by Region (2027–2032)

Table 20. NAD+ Enhancer Market Trends

Table 21. NAD+ Enhancer Market Drivers

Table 22. NAD+ Enhancer Market Challenges

Table 23. NAD+ Enhancer Market Restraints

Table 24. Global NAD+ Enhancer Revenue by Players (US$ Million), 2021–2026

Table 25. Global NAD+ Enhancer Market Share by Players (2021–2026)

Table 26. Global Top NAD+ Enhancer Players by Tier (Tier 1, Tier 2, and Tier 3), based on NAD+ Enhancer Revenue, 2025

Table 27. Ranking of Global Top NAD+ Enhancer Companies by Revenue (US$ Million) in 2025

Table 28. Global 5 Largest Players Market Share by NAD+ Enhancer Revenue (CR5 and HHI), 2021–2026

Table 29. Global Key Players of NAD+ Enhancer, Headquarters and Area Served

Table 30. Global Key Players of NAD+ Enhancer, Products and Applications

Table 31. Global Key Players of NAD+ Enhancer, Date of General Availability (GA)

Table 32. Mergers and Acquisitions, Expansion Plans

Table 33. Global NAD+ Enhancer Market Size by Type (US$ Million), 2021–2026

Table 34. Global NAD+ Enhancer Revenue Market Share by Type (2021–2026)

Table 35. Global NAD+ Enhancer Forecasted Market Size by Type (US$ Million), 2027–2032

Table 36. Global NAD+ Enhancer Revenue Market Share by Type (2027–2032)

Table 37. Global NAD+ Enhancer Market Size by Application (US$ Million), 2021–2026

Table 38. Global NAD+ Enhancer Revenue Market Share by Application (2021–2026)

Table 39. Global NAD+ Enhancer Forecasted Market Size by Application (US$ Million), 2027–2032

Table 40. Global NAD+ Enhancer Revenue Market Share by Application (2027–2032)

Table 41. North America NAD+ Enhancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. North America NAD+ Enhancer Market Size by Country (US$ Million), 2021–2026

Table 43. North America NAD+ Enhancer Market Size by Country (US$ Million), 2027–2032

Table 44. Europe NAD+ Enhancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Europe NAD+ Enhancer Market Size by Country (US$ Million), 2021–2026

Table 46. Europe NAD+ Enhancer Market Size by Country (US$ Million), 2027–2032

Table 47. Asia-Pacific NAD+ Enhancer Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 48. Asia-Pacific NAD+ Enhancer Market Size by Region (US$ Million), 2021–2026

Table 49. Asia-Pacific NAD+ Enhancer Market Size by Region (US$ Million), 2027–2032

Table 50. Latin America NAD+ Enhancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 51. Latin America NAD+ Enhancer Market Size by Country (US$ Million), 2021–2026

Table 52. Latin America NAD+ Enhancer Market Size by Country (US$ Million), 2027–2032

Table 53. Middle East & Africa NAD+ Enhancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 54. Middle East & Africa NAD+ Enhancer Market Size by Country (US$ Million), 2021–2026

Table 55. Middle East & Africa NAD+ Enhancer Market Size by Country (US$ Million), 2027–2032

Table 56. GeneHarbor Company Details

Table 57. GeneHarbor Business Overview

Table 58. GeneHarbor NAD+ Enhancer Product

Table 59. GeneHarbor Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 60. GeneHarbor Recent Development

Table 61. Niagen Bioscience Company Details

Table 62. Niagen Bioscience Business Overview

Table 63. Niagen Bioscience NAD+ Enhancer Product

Table 64. Niagen Bioscience Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 65. Niagen Bioscience Recent Development

Table 66. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Details

Table 67. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview

Table 68. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product

Table 69. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 70. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Development

Table 71. Herbalmax Company Details

Table 72. Herbalmax Business Overview

Table 73. Herbalmax NAD+ Enhancer Product

Table 74. Herbalmax Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 75. Herbalmax Recent Development

Table 76. EffePharm Company Details

Table 77. EffePharm Business Overview

Table 78. EffePharm NAD+ Enhancer Product

Table 79. EffePharm Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 80. EffePharm Recent Development

Table 81. Kingdomway Company Details

Table 82. Kingdomway Business Overview

Table 83. Kingdomway NAD+ Enhancer Product

Table 84. Kingdomway Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 85. Kingdomway Recent Development

Table 86. NOMON Co., Ltd. (Teijin) Company Details

Table 87. NOMON Co., Ltd. (Teijin) Business Overview

Table 88. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product

Table 89. NOMON Co., Ltd. (Teijin) Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 90. NOMON Co., Ltd. (Teijin) Recent Development

Table 91. CELFULL Company Details

Table 92. CELFULL Business Overview

Table 93. CELFULL NAD+ Enhancer Product

Table 94. CELFULL Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 95. CELFULL Recent Development

Table 96. Bontac Company Details

Table 97. Bontac Business Overview

Table 98. Bontac NAD+ Enhancer Product

Table 99. Bontac Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 100. Bontac Recent Development

Table 101. Genex Formulas Company Details

Table 102. Genex Formulas Business Overview

Table 103. Genex Formulas NAD+ Enhancer Product

Table 104. Genex Formulas Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 105. Genex Formulas Recent Development

Table 106. EZZ Company Details

Table 107. EZZ Business Overview

Table 108. EZZ NAD+ Enhancer Product

Table 109. EZZ Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 110. EZZ Recent Development

Table 111. Maac10 Formulas Company Details

Table 112. Maac10 Formulas Business Overview

Table 113. Maac10 Formulas NAD+ Enhancer Product

Table 114. Maac10 Formulas Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 115. Maac10 Formulas Recent Development

Table 116. Elysium Health Company Details

Table 117. Elysium Health Business Overview

Table 118. Elysium Health NAD+ Enhancer Product

Table 119. Elysium Health Revenue in NAD+ Enhancer Business (US$ Million), 2021–2026

Table 120. Elysium Health Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. NAD+ Enhancer Picture

Figure 2. Global NAD+ Enhancer Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global NAD+ Enhancer Market Share by Type: 2025 vs 2032

Figure 4. Content ＜98% Features

Figure 5. Content ≥98% Features

Figure 6. Global NAD+ Enhancer Market Size Comparison by Form (US$ Million), 2021–2032

Figure 7. Powder Features

Figure 8. Liquid Features

Figure 9. Others Features

Figure 10. Global NAD+ Enhancer Market Size Comparison by Ingestion Method (US$ Million), 2021–2032

Figure 11. Dietary Supplements Features

Figure 12. Pharmaceutical Drugs Features

Figure 13. Functional Foods & Beverages Features

Figure 14. IV Infusion Products Features

Figure 15. Others Features

Figure 16. Global NAD+ Enhancer Market Size by Application (US$ Million), 2021–2032

Figure 17. Global NAD+ Enhancer Market Share by Application: 2025 vs 2032

Figure 18. Health Care Products Case Studies

Figure 19. ClinicsBeauty Products Case Studies

Figure 20. Others Case Studies

Figure 21. NAD+ Enhancer Report Years Considered

Figure 22. Global NAD+ Enhancer Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 23. Global NAD+ Enhancer Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 24. Global NAD+ Enhancer Market Share by Region: 2025 vs 2032

Figure 25. Global NAD+ Enhancer Market Share by Players in 2025

Figure 26. Global NAD+ Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 27. The Top 10 and 5 Players Market Share by NAD+ Enhancer Revenue in 2025

Figure 28. North America NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. North America NAD+ Enhancer Market Share by Country (2021–2032)

Figure 30. United States NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Canada NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Europe NAD+ Enhancer Market Share by Country (2021–2032)

Figure 34. Germany NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. France NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. U.K. NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Italy NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Russia NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Ireland NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Asia-Pacific NAD+ Enhancer Market Share by Region (2021–2032)

Figure 42. China NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Japan NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. South Korea NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Southeast Asia NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. India NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Australia & New Zealand NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Latin America NAD+ Enhancer Market Share by Country (2021–2032)

Figure 50. Mexico NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Brazil NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Middle East & Africa NAD+ Enhancer Market Share by Country (2021–2032)

Figure 54. Israel NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Saudi Arabia NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. UAE NAD+ Enhancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. GeneHarbor Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 58. Niagen Bioscience Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 59. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 60. Herbalmax Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 61. EffePharm Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 62. Kingdomway Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 63. NOMON Co., Ltd. (Teijin) Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 64. CELFULL Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 65. Bontac Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 66. Genex Formulas Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 67. EZZ Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 68. Maac10 Formulas Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 69. Elysium Health Revenue Growth Rate in NAD+ Enhancer Business (2021–2026)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global NAD Booster Capsule Market Research Report 2024

Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Research Report 2025

Global Nicotinamide Adenine Dinucleotide NAD Market Insights Forecast to 2030

Global NAD Supplements Market Research Report 2024

Global NAD Anti Aging Nutraceuticals Market Research Report 2024

Global NMN Raw Materials Market Research Report 2025

Global Nicotinamide Mononucleotide NMN Market Research Report 2025

Global NMN Health Supplement Market Research Report 2024

Global β NMN Supplements Market Research Report 2024

Global Beta Nicotinamide Mononucleotide NMN Market Research Report 2025

Global NAD Anti Ageing Supplements Market Research Report 2024

Global NAD Anti Aging Products Market Research Report 2024

Global NAD Intravenous Therapy Market Research Report 2024

Global NADP NADPH Assay Kit Market Research Report 2025

Global Mobile In Home NAD IV Therapy Market Research Report 2024

Global β Nicotinamide Mononucleotide NMN Market Research Report 2025

Global Nicotinamide Ribose NR Market Insights Forecast to 2030

Global NMN Capsule Market Research Report 2024

Global Nicotinamide NAA aka Niacinamide Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions